Deerfield

Deerfield is an investment firm that transforms healthcare through information, investment, and philanthropy.

Business Model:

Revenue: $20M

Employees: 51-200

Rankings

Detailed Deerfield Information

Geographic Data

Deerfield headquarters map

Address: 345 Park Avenue South

City: New York

State: NY

Zip: 10010

Country: US

Financial Info

Stage:

Raised Last:

$25M

Raised Total:

$25M

Metrics

1,373,580Website Global Rank

17,484Website Monthly Traffic

Twitter Followers

Description

Deerfield is an investment management firm. They provide a healthcare ecosystem through information and investment. They also provide private and public investments across the life science, medical device, diagnostic, digital health, and health service industries.

Contact Phone:
+12125511600

Contact Email:

Announced Date Company Transaction Money Raised
2/2022 ConcertoCare Series B 105M
1/2021 FogPharma Series C 107M
10/2018 Pinnacle Hill Venture Round 65M
3/2006 Breathe Technologies Series A 4M
10/2017 Broad Institute Venture Round 50M
8/2022 Insilico Medicine Series D 35M
2/2021 Spectrawave Series A 13.2M
4/2016 Lumeris Venture Round 80M
2/2018 Collage Rehabilitation Partners Private Equity Round -
8/2017 Homology Medicines Series B 83.5M
1/2012 iCAD Post-IPO Debt 15M
5/2020 LetsGetChecked Series C 71M
11/2016 Recovery Centers of America Private Equity Round 100M
2/2021 Xilio Therapeutics Series C 95M
2/2022 Vibliome Series A 38M
2/2018 Generation Bio Series B 100M
12/2020 Edgewise Therapeutics Series C 95M
5/2021 Larimar Therapeutics Post-IPO Equity 0
1/2016 Advantia Health Venture Round -
4/2023 Cortica Series D 0
1/2021 Terns Pharmaceuticals Series C 87M
12/2019 Black Diamond Therapeutics Series C 0
5/2017 Xeris Pharmaceuticals Series C 0
11/2017 Melinta Therapeutics Post-IPO Debt 240M
1/2019 Black Diamond Therapeutics Series B 85M
7/2021 Sema4 Post-IPO Equity 350M
1/2015 AveXis Series C 10M
10/2016 Bridge Medicines Venture Round -
10/2007 TALON THERAPEUTICS Post-IPO Debt 30M
1/2019 Stelexis Therapeutics Series A 43M
11/2018 InCarda Therapeutics Series B 42M
6/2019 Frontier Medicines Series A 67M
5/2016 GrayBug Series B 44.5M
6/2021 Adela Series A 60M
6/2011 TESARO Series B 101M
1/2012 TALON THERAPEUTICS Post-IPO Equity 10.3M
4/2022 Apertura Gene Therapy Series A 67M
8/2021 Pepgen Venture Round 0
5/2020 ARTMS Series A 19M
1/2021 Nuvalent Series A 50M
2/2016 Ribon Therapeutics Series A 24M
10/2014 MedAvail Series C 0
1/2015 Global Blood Therapeutics Series B 48M
3/2020 Ready Series B 48M
7/2022 MMI Series B 0
12/2007 Third Wave Technologies Post-IPO Equity 25M
12/2014 Audentes Therapeutics Series B 42.5M
1/2015 Breathe Technologies Venture Round 810k
10/2021 DeepSight Technology Series A 0
5/2016 Neos Therapeutics Post-IPO Debt 60M
9/2015 AveXis Series D 65M
7/2010 Nivalis Therapeutics Series B 0
2/2018 Kiniksa Pharmaceuticals Series C 200M
3/2015 aTyr Pharma Series E 76M
11/2016 Shockwave Medical Series C 45M
7/2016 Oncorus Series A 57M
11/2016 ConcertoCare Venture Round 30M
1/2014 Auspex Pharmaceuticals Series E 0
1/2016 Syros Pharmaceuticals Series C 40M
4/2021 GH Research Series B 125M
2/2021 Nuvation Bio Post-IPO Equity 502M
1/2020 Generation Bio Series C 110M
5/2023 Ray Therapeutics Series A 0
3/2020 Element Science Series C 145.6M
4/2018 Arvinas Series C 55M
2/2016 Synlogic Series B 40M
9/2019 Nkarta Therapeutics Series B 114M
7/2013 Dicerna Pharmaceuticals Series C 0
3/2020 RubiconMD Series C 18M
1/2020 Neomorph Seed Round -
5/2015 Shockwave Medical Series B 40M
3/2018 Pairwise Plants Series A 25M
9/2015 Akari Therapeutics Post-IPO Equity 0
7/2022 Vicinitas Therapeutics Series A 65M
3/2014 Kolltan Pharmaceuticals Series D 60M
6/2023 Bitterroot Bio Series A 0
8/2015 Rhythm Metabolic Series A 40M
1/2019 Schrödinger Series E 0
4/2021 Jaguar Gene Therapy Series B 0
3/2021 Xeris Pharmaceuticals Post-IPO Equity 27M
12/2020 Cystetic Medicines Funding Round 0
9/2013 IMRIS Inc. Post-IPO Debt 36.8M
2/2013 Éclat Pharmaceuticals Post-IPO Debt 10.5M
3/2011 Titan Pharmaceuticals Post-IPO Debt 20M
2/2020 Farapulse Venture Round -
9/2018 Poseidon Innovation Venture Round 65M
12/2020 Octave Bioscience Series B 32M
3/2014 Wellfount Venture Round 15M
9/2016 SentreHEART Series D 35M
3/2015 EndoChoice Series D 57M
1/2021 MIVI Neuroscience Series B 35M
11/2021 The Oncology Institute of Hope and Innovation Post-IPO Equity 275M
5/2016 Homology Medicines Series A 43.5M
10/2022 Pleno Series A 0
2/2022 Somatus Series E 0
3/2021 Crossover Health Series D 0
9/2008 Ista Pharmaceuticals Debt Financing 65M
6/2015 NeoChord Series C 0
4/2016 Lumos Pharma Series B 34M
9/2021 HilleVax Equity 135M
12/2014 Conventus Orthopaedics Series A 0
6/2018 Appello Pharmaceuticals Series A 15.5M
4/2021 Cohere Health Series B 36.1M
8/2019 Oncorus Series B 0
6/2016 Blade Therapeutics Series B 45M
3/2018 Dracen Pharmaceuticals Series A 40M
4/2018 Sollis Therapeutics Venture Round 0
8/2021 ARS Pharmaceuticals Series D 55M
5/2021 Nuvalent Series B 0
4/2018 Constellation Pharmaceuticals Series F 0
5/2014 Proteon Therapeutics Series D 0
7/2021 Strata Oncology Series C 0
6/2015 CytomX Therapeutics Series D 70M
6/2021 Ribon Therapeutics Series C 0
3/2021 Graphite Bio Series B 150.7M
6/2021 RayzeBio Series C 108M
6/2009 Arena Pharmaceuticals Post-IPO Equity 151.8M
11/2014 Alimera Sciences Post-IPO Equity 50M
5/2020 CorVent Medical Seed Round 0
7/2012 Nektar Therapeutics Post-IPO Debt 125M
11/2020 Bridge Medicines Equity 10M
9/2018 ARS Pharmaceuticals Series C 20M
10/2020 InCarda Therapeutics Series C 30M
6/2018 Cureatr Venture Round 3M
5/2021 ADC Therapeutics Post-IPO Debt 50M
2/2021 Pairwise Plants Series B 90M
9/2022 Innervace Series A 40M
11/2013 TriVascular Series E 0
4/2018 V-Wave Series C 0
10/2021 Lark Series D 0
12/2021 Hyperfine Post-IPO Equity 0
2/2015 Tonix Pharmaceuticals Post-IPO Equity 28.7M
6/2015 Cureatr Series B 0
4/2014 Adverum Biotechnologies Series B 55M
10/2017 Phoenix Venture Round 12M
6/2023 Presidio Medical Series C 0
2/2023 Abivax Post-IPO Equity 0
11/2022 Abeona Therapeutics Post-IPO Equity 0
11/2022 Intus Care Series A 0
6/2021 Synthekine Series B 0
11/2022 FogPharma Series D 0
9/2020 Ready Series C 54M
6/2021 Novocardia Series A 53.7M
7/2013 MannKind Post-IPO Debt 160M
10/2015 American Addiction Centers Post-IPO Equity 100M
7/2020 Annexon Biosciences Series C 100M
5/2020 Intersect ENT Post-IPO Equity 65M
7/2017 Farapulse Venture Round 5M
1/2016 Aprecia Pharmaceuticals Venture Round 35M
6/2022 Insilico Medicine Series D 0
3/2019 TriNetX Series D 40M
5/2019 Aerie Pharmaceuticals Post-IPO Debt 200M
12/2015 Recovery Centers of America Private Equity Round 231.5M
1/2016 Xeris Pharmaceuticals Series C 41M
3/2016 Acutus Medical Series C 75M
3/2009 Insulet Post-IPO Debt 60M
9/2020 V-Wave Series C 0
8/2020 Reprieve Cardiovascular Series A 15M
2/2021 Jaguar Gene Therapy Series A -
6/2014 KemPharm Debt Financing 60M
4/2014 Infinity Pharmaceuticals Post-IPO Debt 100M
6/2017 Aziyo Biologics Venture Round 12M
9/2010 New American Therapeutics Venture Round 53M
1/2016 ESSA Pharma Post-IPO Equity 15M
2/2023 IronMatt Grant 75k
4/2013 SERMO Venture Round 35M
5/2011 WaferGen Biosystems Post-IPO Equity 0
6/2010 Exelixis Post-IPO Debt 160M
11/2020 Springtide Child Development Series A 18M
1/2011 Veterinary Practice Partners Venture Round 10M
4/2021 Vesta Healthcare Venture Round 65M
4/2011 Cytokinetics Post-IPO Equity 20M
5/2012 MAKO Surgical Post-IPO Debt 50M
10/2020 Olema Oncology Series C 85M
6/2008 ZymoGenetics Post-IPO Debt 100M
5/2017 Synlogic Series C 42M
3/2015 Assertio Post-IPO Debt 575M
3/2021 Happify Series D 0
12/2011 Flamel Technologies Post-IPO Equity 16M
1/2018 Concert Genetics Venture Round -
6/2008 Exelixis Post-IPO Debt 150M
2/2013 PacBio Post-IPO Debt 20.5M
12/2015 Hallux, Inc. Series A 7.1M
9/2019 Edgewise Therapeutics Series B 50M
5/2021 Adaptive Phage Therapeutics Series B 40.8M
4/2022 Aurion Biotechnologies Venture Round 120M
6/2011 BioHorizons Debt Financing 50M
2/2013 Flamel Technologies Post-IPO Debt 15M
6/2020 Meditrina, Inc Venture Round 10M
5/2008 Array BioPharma Post-IPO Debt 80M
10/2014 SHINE Technologies Debt Financing -
4/2014 OMNILife science, Inc. Debt Financing 27.5M
11/2018 SHINE Medical Technologies Debt Financing 150M
6/2020 Somatus Series C 64M
6/2014 Nuo Therapeutics Post-IPO Debt 35M
11/2017 Fractyl Health Series D 0
10/2014 SHINE Technologies Venture Round 125M
7/2021 Frontier Medicines Series B 0
1/2021 Werewolf Therapeutics Series B 0
6/2010 TALON THERAPEUTICS Post-IPO Equity 100M
1/2015 REGENXBIO Series C 30M
7/2020 Liquid Wire Series A 10M
5/2020 Great Lakes Discoveries LLC Funding Round 130M
9/2013 Intra-Cellular Therapies Secondary Market 60M
11/2019 Contessa Series D 32.5M
3/2018 Ancora Innovation Venture Round 65M
3/2014 ATEC Post-IPO Debt 50M
7/2016 Ardelyx Post-IPO Equity 0
11/2007 MiddleBrook Pharmaceuticals, Inc Post-IPO Equity 10M
8/2014 Epion Health Series A 6.8M
8/2017 MIVI Neuroscience Debt Financing 4M
12/2019 Civetta Series A 53M
10/2017 Adeptus Health Post-IPO Debt 257.7M
5/2020 ADC Therapeutics Post-IPO Debt 65M
4/2008 VIVUS Post-IPO Debt 20M
6/2016 FogPharma Series A 11M
6/2021 Insilico Medicine Series C 0
1/2021 Encodia Series C 75M
2/2006 NeoRX Corporation (Poniard Pharmaceuticals) Post-IPO Equity 65M
6/2014 Horizon Pharma Post-IPO Debt 300M
7/2007 Dynavax Technologies Post-IPO Debt 30M
4/2022 Acutus Medical Post-IPO Debt 35M
12/2019 Four Points Innovation Funding Round 130M
10/2018 Tris Pharma Debt Financing 125M
2/2017 Chondrial Therapeutics Series A 22.6M
5/2014 Spark Therapeutics Series B 72.8M
2/2019 CathWorks Series C 30M
7/2010 Pacific Biosciences Series F 0
6/2021 Talkspace Post-IPO Equity 0
6/2021 CareMax Post-IPO Equity 0
6/2018 Lakeside Discovery Venture Round 65M
10/2020 Curation Health Series A -
4/2015 Voyager Therapeutics Series B 0
1/2023 Perceive Biotherapeutics Series B 0
12/2020 Neomorph Series A 109M
6/2017 Proteon Therapeutics Post-IPO Equity 22M
7/2020 Sema4 Series C 121M
4/2022 Valneva Post-IPO Debt 20M
4/2017 Endologix Post-IPO Debt 170M
8/2015 RedBrick Health Venture Round 30M
6/2022 Epic Sciences Series F 0
5/2009 Array BioPharma Post-IPO Debt 40M
2/2015 SteadyMed Therapeutics Venture Round 12.2M
1/2020 Vesta Healthcare Series A 30M
6/2015 Aralez Pharmaceuticals Post-IPO Equity 0
10/2015 Audentes Therapeutics Series C 65M
9/2021 BioAtla Post-IPO Equity 0
5/2015 Vital Access Debt Financing 10M
2/2013 Windtree Therapeutics Post-IPO Debt 30M
7/2020 AdaptHealth Post-IPO Equity 0
7/2019 Axon Therapies Series A -
5/2008 NxStage Medical Post-IPO Equity 5.6M
11/2015 Fractyl Health Series C 57M
1/2017 Vescor Therapeutics Seed Round -
6/2023 Presidio Medical Series C 0
6/2023 Bitterroot Bio Series A 0
5/2023 Ray Therapeutics Series A 0
4/2023 Cortica Series D 0
2/2023 Abivax Post-IPO Equity 0
2/2023 IronMatt Grant 0
1/2023 Perceive Biotherapeutics Series B 0
11/2022 FogPharma Series D 0
11/2022 Abeona Therapeutics Post-IPO Equity 0
11/2022 Intus Care Series A 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research